Indefinite Delivery Contract SPE2D225D0017
- Not listed
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-oriented federal agency, on June 24, 2025, with an ultimate completion date of June 23, 2030. The contract, valued at $3,747,593.24, establishes a national requirements vehicle for the supply of Lansoprazole 30 milligram capsules in 100-count bottles to multiple federal healthcare systems. The underlying solicitation, issued as a pre-solicitation...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-oriented federal agency, effective August 29, 2023, with an ultimate completion date of August 29, 2028. The contract, valued at approximately $3.02 million, was not issued under any set-aside designation, indicating competitive procurement. The awardee is a for-profit pharmaceutical manufacturer and distributor headquartered in Calorillo,...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, on May 24, 2021, following a pre-solicitation opportunity posted on August 25, 2020. The contract, valued at $4.55 million with an ultimate completion date of May 23, 2026, carries no set-aside restrictions and reflects the contractor's competitive standing in open federal procurement processes. Golden State Medical Supply...
- Golden State Medical Supply, Inc. has been awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, to provide pharmaceutical products to federal government healthcare systems. The contract, effective from September 27, 2023, through September 26, 2028, carries a ceiling value of $3,988,286.45 and encompasses the procurement category of pharmaceuticals (North American Industry Classification System code 4610105551). This IDV was issued...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical and medical products. The contract has a potential value of $3,651,502.35 and a period of performance from October 18, 2018 to October 17, 2023. Through this single-award IDV, Golden State Medical Supply provides a range of pharmaceutical products, including heartburn medications, diabetes drugs,...
- This single-award Indefinite Delivery Contract was awarded on January 26, 2022 by the Medical Supply Chain (alternate name for the Defense Logistics Agency) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $24,393,556.55 and an ultimate completion date of January 25, 2027. The contract is focused on the manufacture and distribution of a wide range of essential pharmaceutical...
- The federal contract IDV award is for the supply of Solifenacin Succinate 10mg and 5mg tablets to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite-delivery contract was issued by the VA National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor, for a period of performance from August 2020 to August 2025 with a ceiling value of $3,218,821.85. The contract...
- Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide pharmaceutical products. The contract facilitates orders for prazusrel hydrochloride 5mg and 10mg tablets to VA hospitals and facilities through February 2025. With a potential value of $3,892,430.05, the contract leverages Golden State Medical Supply's distribution network to deliver specified medications on an as-needed basis...
- Golden State Medical Supply, Inc. (Camarillo, California) holds a single-award Indefinite Delivery Contract with the Medical Supply Chain, a Defense agency component, with a ceiling value of $6,883,760.65 and an ultimate completion date of November 15, 2027. This contract, awarded November 16, 2017, utilizes no set-aside designation and operates under a firm fixed-price structure. The contract encompasses the manufacture and distribution of pharmaceutical products to support federal defense...
- Golden State Medical Supply, Inc., a pharmaceutical manufacturer and distributor headquartered in Camarillo, California, was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain (Defense) on September 30, 2020, with a contract ceiling value of approximately $4.74 million. This IDV, which originated from a pre-solicitation posted on March 26, 2020, was awarded without any set-aside restrictions, reflecting the contractor's competitive standing in open federal...
Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) has been awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, for the supply of Solifenacin Succinate tablets. The contract, with a ceiling value of $2.38 million and a performance period extending from September 18, 2025 through September 17, 2030, provides pharmaceutical supply services to Department of Defense, Indian Health Service, and Bureau of Prisons customers through the Defense Logistics Agency prime vendor program. The procurement encompasses Solifenacin tablets in both 5 milligram and 10 milligram strengths, packaged in 30-count and 90-count bottles, under a firm-fixed price, requirements-type contracting structure. This acquisition was solicited as a fully competitive, unrestricted commercial item purchase under Federal Acquisition Regulation Part 12, with no set-asides applied, allowing all qualified vendors to compete. The contract is structured with a one-year base period and four one-year option periods, enabling sustained pharmaceutical supply management across the federal healthcare system. The originating pre-solicitation, posted March 27, 2025, with a projected solicitation date in April 2025, was issued through the Defense Logistics Agency Troop Support Medical using the DLA Bid Board System and SAM.gov as procurement channels. As a manufacturer and distributor of pharmaceutical products based in Calorillo, California, Golden State Medical Supply brings established federal contracting experience, having previously secured multiple single-award Indefinite Delivery Contracts with the Veterans Affairs National Acquisition Center and Defense Logistics Agency for various pharmaceutical products. This contract aligns with Golden State Medical Supply's core business operations serving federal healthcare facilities and contributes to the continuity of essential medication supply for Department of Defense and other federal health service networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/18/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Solifenacin | SPE2D2-25-R-0011 | Defense Logistics Agency Troop Support Medical | Solicitation 2/3 | 4/29/25, 2:55 PM | |
Solifenacin Award | SPE2D2-25-D-0017 | Defense Logistics Agency Troop Support Medical | Award Notice 3/3 | 9/23/25, 1:43 PM | |
Solifenacin | SPE2D2-25-R-0011 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/3 | 3/27/25, 4:08 PM |